Tessera Therapeutics
David Tefft has extensive experience in software engineering and lab automation, having held various senior director and engineering manager roles at companies such as Tessera Therapeutics, Gritstone bio, N-of-One, Inc., and Good Start Genetics. With a background in Biochemistry and Molecular Biology from the University of Massachusetts Amherst, David has demonstrated proficiency in software development throughout their career, including positions at Zipcar, The Broad Institute, Case Western Reserve University, and Variagenics.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.